financetom
Business
financetom
/
Business
/
Innate Pharma Names Jonathan Dickinson as New CEO, Chairman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Innate Pharma Names Jonathan Dickinson as New CEO, Chairman
Oct 14, 2024 6:22 PM

03:29 AM EDT, 10/14/2024 (MT Newswires) -- Innate Pharma SA ( IPHA ) said Monday it has appointed Jonathan Dickinson as chief executive officer and chairman of the executive board, effective Nov. 1, replacing Herve Brailly.

Dickinson most recently served as executive vice president and general manager for Europe at Incyte ( INCY ) .

Brailly, who served as interim CEO, will stay in an advisory role during the transition process, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved